<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02744404</url>
  </required_header>
  <id_info>
    <org_study_id>Malawi POC EID</org_study_id>
    <nct_id>NCT02744404</nct_id>
  </id_info>
  <brief_title>Point of Care Early Infant Diagnosis Patient Impact Study</brief_title>
  <official_title>Evaluation of the Clinical Impact of Point-of-Care HIV Early Infant Diagnostic Technologies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinton Health Access Initiative Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Malawi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>UNICEF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinton Health Access Initiative Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In Malawi, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of
      age) is conducted using molecular diagnostics at central laboratories. However, test volumes
      are growing and many parts of the country do not have close or easy access to laboratories.
      Test samples are transported over large distances and this can introduce testing delays,
      especially for patients in rural and remote areas of the country. There are growing numbers
      of high quality Point-Of-Care (POC) diagnostic technologies available and there is increasing
      interest in using these technologies to alleviate critical testing needs. This protocol
      describes an observational study looking at the patient impact of implementing POC EID
      technologies within the routine standard of care at seven facilities.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ART initiation retention</measure>
    <time_frame>6-9 months</time_frame>
    <description>Proportion of HIV-positive infants initiated on anti-retroviral therapy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Test turnaround time</measure>
    <time_frame>6-9 months</time_frame>
    <description>Number of days from testing to result being received by the health care facility</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tests received</measure>
    <time_frame>6-9 months</time_frame>
    <description>Proportion of tests received by the health care facility</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>POC EID</arm_group_label>
    <description>Point of Care Early Infant Diagnosis qualitative technologies (Alere q) will be implemented. Sample collection and testing will happen in the same location within the health care facility.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laboratory-based testing</arm_group_label>
    <description>Conventional laboratory-based testing using the Abbott m2000 technology will continue to be used per standard of care in Malawi. Dried blood spot samples will be collected at health care facilities and transported within the national network to centralized laboratories for testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POC EID</intervention_name>
    <arm_group_label>POC EID</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be mother-infant pairs from the general population attending the
        seven clinics for routine HIV-related, PMTCT and post-natal care services. Study subjects
        will be infants from mother-infant pairs presenting consecutively to the clinic for EID
        testing per the national EID guidelines during the study period.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Younger than 12 months of age

          -  Clinical or other indication for an EID test (screen or confirmation), such as birth
             to an HIV-positive mother

        Exclusion Criteria:

          -  Older than 12 months of age

          -  Serious medical conditions which would make testing dangerous for the infant, or
             disrupt the accuracy of normal laboratory analysis and its interpretation

          -  Already initiated ART
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kamuzu Central Hospital</name>
      <address>
        <city>Lilongwe</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Machinga District Hospital</name>
      <address>
        <city>Liwonde</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mzuzu Central Hospital</name>
      <address>
        <city>Mzuzu</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nsanama Health Center</name>
      <address>
        <city>Nsanama</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ntaja Health Center</name>
      <address>
        <city>Ntaja</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ntcheu District Hospital</name>
      <address>
        <city>Ntcheu</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Migowi Health Center</name>
      <address>
        <city>Phalombe</city>
        <country>Malawi</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reuben Mwenda</last_name>
      <email>remwenda@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Malawi</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2016</study_first_submitted>
  <study_first_submitted_qc>April 15, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2016</study_first_posted>
  <last_update_submitted>August 1, 2016</last_update_submitted>
  <last_update_submitted_qc>August 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

